Cell and Organ Cultures for Studying Retinal Diseases
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 18334
Special Issue Editors
Interests: glaucoma; age-related macular degeneration; retinal diseases; retinal organ culture models; autoimmunity; neuroprotection
Special Issues, Collections and Topics in MDPI journals
Interests: retinal organ culture models; glaucoma; retinal diseases; neuroprotection; ocular drug delivery; nanoparticles; ocular gene delivery; aptamers; AMD; IRD
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
For many retinal diseases, including age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy (DR), the exact pathogenesis is still unclear. Moreover, the currently available therapeutic options are often unsatisfactory.
To date, research regarding these diseases has mainly relied on animal models. However, animal models do not fully mimic human diseases. In addition, there is growing pressure from society to reduce animal research. This creates a need for alternative and improved disease models.
This Special Issue includes original research and review articles about recent developments regarding in vitro models for retinal diseases.
The topics of this Special Issue include but are not limited to:
- The development of in vitro and ex vivo models (e.g., primary cell cultures, organotypic cultures, organoids, and whole eye cultures);
- The analysis and validation of causative molecular pathways and pathomechanisms;
- Treatment development and testing.
Prof. Dr. Stephanie C. Joachim
Dr. Sven Schnichels
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cell culture
- Organ culture
- Ex vivo
- Retina culture
- In vitro
- Primary cell cultures
- Organotypic cultures
- Whole eye cultures
- Organoids
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.